Paramount Group, Inc. (PGRE)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-78.15	-46.29	-259.74	-36.4	-20.35	-24.7
Depreciation & Amortization	229.95	233.72	245.27	230.77	229.42	230.47
Other Amortization	11.65	10.25	6.22	6.16	9.13	9.28
Gain (Loss) on Sale of Investments	-	0.78	107.72	-	-1.54	-1.92
Stock-Based Compensation	20.49	20.14	20.32	19	18.61	19.24
Income (Loss) on Equity Investments	44.02	47.85	288.33	57.13	32.07	22.96
Change in Accounts Receivable	-9.91	-0.18	5.81	-8.28	1.92	1.73
Change in Accounts Payable	-4.95	8.25	-13.66	3.66	16.25	-1.3
Change in Other Net Operating Assets	-8.6	4.21	-6.65	-23.81	-64.26	-9.64
Other Operating Activities	0.65	-13.8	-115.76	-1.58	23.06	-22.3
Net Cash from Discontinued Operations	-	-	-	-	-	13.46
Operating Cash Flow	205.15	264.93	277.86	246.64	244.31	237.27
Operating Cash Flow Growth	-25.85%	-4.66%	12.66%	0.95%	2.96%	-16.88%
Acquisition of Real Estate Assets	-127.09	-118.16	-100.53	-125.81	-112	-89.46
Net Sale / Acq. of Real Estate Assets	-127.09	-118.16	-100.53	-125.81	-112	-89.46
Investment in Marketable & Equity Securities	2.35	-0.95	-42.79	-26.78	-10.15	33.91
Other Investing Activities	-	-	3.22	-	18.67	95.59
Investing Cash Flow	-114.74	-109.11	-160.1	-152.58	-103.48	40.04
Long-Term Debt Issued	-	850	232.05	-	888.57	172.87
Long-Term Debt Repaid	-	-975	-273	-	-850	-208.77
Total Debt Repaid	-	-975	-273	-	-850	-208.77
Net Debt Issued (Repaid)	-	-125	-40.95	-	38.57	-35.9
Repurchase of Common Stock	-0.15	-0.19	-0.21	-63.44	-0.24	-120.33
Common Dividends Paid	-8.38	-25.12	-52.68	-73.02	-67.48	-98.06
Other Financing Activities	105.59	40.33	35.86	-37.44	-47.33	110.82
Net Cash Flow	187.47	45.85	59.78	-79.85	64.34	133.84
Cash Interest Paid	159.71	156.19	144.39	139.33	132.48	135.61
Cash Income Tax Paid	1.85	2.03	0.89	2.71	1.76	1.37
Levered Free Cash Flow	134.16	115.68	33.94	188.88	316.9	338.83
Unlevered Free Cash Flow	230.12	209.78	123.34	272.64	396.06	419.68
Change in Net Working Capital	65.97	107.33	57.92	49.92	-57.02	-89.86

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.

SEC Filings: 10-K · 10-Q